Skip to content
Forest Global Training Partners
Home Services AI Governance AI Risk Encyclopedia Contact Us
AI Risk Encyclopedia AI Use CasesAI RisksAI Hallucinations Topics Entities Sources
  1. Home
  2. AI Risks
  3. Phesi CEO on why phase 3 clinical trials fail - R&D World

AI Risks July 31, 2025 · R&D World

Phesi CEO on why phase 3 clinical trials fail - R&D World

... failed between 2000 and 2015. However, AI and big data could help save trials from failure . Credit: Phesi. A report from Phesi, a clinical data ...

Read the original at R&D World ↗

Topics
HealthcareBanking & Finance
Tracked via
“AI Falures”

Related articles

  • FDA asked to clarify AI pilot objectives for early-phase clinical trials | RAPS AI Risks · Jul 02, 2026
  • FDA's AI in Early Phase Clinical Trials RFI: An Opportunity to Help Set the Rules of the Road AI Risks · May 11, 2026
  • In Focus:AI and Clinical Trials — 'The Beginning of a Journey' AI Risks · Dec 12, 2024
  • AI Could Reshape Clinical Trials—and the Business of Pharma | TIME AI Risks · Feb 07, 2026
  • HowAICould Ease Tension in Clinical Trials - Bio Space AI Risks · Oct 11, 2024
  • NewAIPlatform Simulates Thousands of Clinical Trials At Once - NoCamels AI Risks · Dec 04, 2023

AI Risk Encyclopedia is a curated research index from Forest Global Training Partners. Articles belong to their publishers; we link to and summarize them.

Contact